TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification

K. W. Maloney, L. McGavran, J. R. Murphy, L. F. Odom, L. Stork, Q. Wei, S. P. Hunger

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification'. Together they form a unique fingerprint.

Medicine & Life Sciences